Table 1.
Variable | Right Ventricular Dysfunction | p Value | |
---|---|---|---|
No (n=92) | Yes (n=49) | ||
Age (years) | 63 ± 16 | 61 ± 17 | 0.56 |
African American | 75 (82%) | 34 (69%) | 0.1 |
Male | 46 (47%) | 30 (61%) | 0.1 |
Systolic blood pressure (mmHg) | 149 ± 31 | 145 ± 34 | 0.49 |
Heart rate (beats per minute) | 80 ± 17 | 85 ± 12 | 0.06 |
General medical service | 71 (77%) | 36 (75%) | 0.77 |
Volume overload on chest X-ray | 46 (71%) | 22 (65%) | 0.54 |
Hemoglobin (g/dL) | 11.9 ± 2.0 | 12.7 ± 2.4 | 0.02* |
Detectable troponin I | 19 (21%) | 16 (33%) | 0.12 |
Blood urea nitrogen (mg/dL) | 19 (14 to 28) | 25 (18 to 33) | 0.07 |
Serum sodium (mg/dL) | 139.7 ± 5.2 | 138.4 ± 4.6 | 0.13 |
Admission glomerular filtration rate (mL/min/1.73m2) | 59.6 ± 29.4 | 70.4 ± 22.8 | 0.03* |
Admission serum creatinine (mg/dL) | 1.3 (1.0 to 1.5) | 1.2 (1.0 to 1.7) | 0.98 |
B-type natriureetic peptide (pg/dL) | 1279 (861 to 2299) | 1987 (1042 to 4000) | 0.003* |
Maximum diuretic dose (mg/day) | 80 (80 to 160) | 120 (80 to 200) | 0.03* |
Thiazide use | 12 (13%) | 7 (14%) | 0.84 |
Net fluid out (L) | 3.9 (1.4 to 5.9) | 4.5 (1.5 to 8.5) | 0.28 |
Length of stay (days) | 4 (3.3 to 6.0) | 6 (4.0 to 8.0) | 0.02* |
Day peak creatinine (days) | 4 (3 to 5) | 2 (2 to 6) | 0.11 |
Ejection fraction (%) | 33 (16 to 55) | 20 (10 to 29) | <0.001* |
Early peak mitral inflow velocity/early peak annular tissue velocity (septal) | 17.7 ± 8.3 | 19.7 ± 12.2 | 0.35 |
Early peak mitral inflow velocity/early peak annular tissue velocity (lateral) | 12.1 ± 5.6 | 12.6 ± 8.3 | 0.68 |
Cardiac output (L/min) | 4.9 ± 1.8 | 4.0 ± 1.7 | 0.01* |
Left atrial size (cm) | 4.7 ± 0.7 | 4.9 ± 0.8 | 0.13 |
Moderate or severe tricuspid regurgitation | 37 (40%) | 29 (59%) | 0.03* |
Lack of inspiratory inferior vena cava collapse | 9 (10%) | 13 (27%) | 0.009* |
represents a significant p value.